{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:24:37Z","timestamp":1783607077661,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04921-6","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:03:01Z","timestamp":1779080581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early neurodevelopmental outcomes in a child with tuberous sclerosis complex treated with everolimus and vigabatrin"],"prefix":"10.1186","volume":"26","author":[{"given":"Sarah ML.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Varnado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Sartwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosleen","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Northrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kay","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"4921_CR1","doi-asserted-by":"crossref","unstructured":"Sparrow S, Cicchetti D, Balla D. Vineland Adaptive Behavior Scales, Second edition. Circle Pines, MN: AGS Publishing; 2005.","DOI":"10.1037\/t15164-000"},{"key":"4921_CR2","doi-asserted-by":"crossref","unstructured":"Bayley N. Bayley scales of infant and toddler development, third edition. San Antonio, TX: PsychCorp; 2006.","DOI":"10.1037\/t14978-000"},{"key":"4921_CR3","doi-asserted-by":"publisher","unstructured":"de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo,P., D\u2019Amato, L., Beure d\u2019Aug\u00e8res, G., Ferreira, J. C., Feucht, M., Fladrowski, C.,Hertzberg, C., Jozwiak, S., Lawson, J. A., Macaya, A., Marques, R., Nabbout, R., O\u2019Callaghan,F., Qin, J., \u2026 Defresne, P. Natural clusters of tuberous sclerosis complex(TSC)-associated neuropsychiatric disorders (TAND): new findings from the TOSCA TAND research project. Journal of Neurodevelopmental Disorders. 2020;12(1), Article 24. https:\/\/doi.org\/10.1186\/s11689-020-09327-0.\u00a0","DOI":"10.1186\/s11689-020-09327-0"},{"issue":"1","key":"4921_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pediatrneurol.2014.10.006","volume":"52","author":"L Leclezio","year":"2015","unstructured":"Leclezio L, Jansen A, Whittemore VH, de Vries PJ. Pilot Validation of the Tuberous Sclerosis-Associated Neuropsychiatric Disorders (TAND) Checklist. Pediatr Neurol. 2015;52(1):16\u201324. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2014.10.006.","journal-title":"Pediatr Neurol"},{"key":"4921_CR5","doi-asserted-by":"publisher","unstructured":"de Vries, P. J., Belousova, E., Benedik, M. P., Carter, T., Cottin, V., Curatolo,P., Dahlin, M., D\u2019Amato, L., d\u2019Aug\u00e8res, G. B., Ferreira, J. C., Feucht, M., Fladrowski,C., Hertzberg, C., Jozwiak, S., Kingswood, J. C., Lawson, J. A., Macaya, A., Marques,R., Nabbout, R., \u2026 Jansen, A. C. TSC-associated neuropsychiatric disorders(TAND): findings from the TOSCA natural history study. Orphanet Journal of Rare (2018).Diseases. 2018;13(1):157\u2013157. https:\/\/doi.org\/10.1186\/s13023-018-0901-8.","DOI":"10.1186\/s13023-018-0901-8"},{"key":"4921_CR6","doi-asserted-by":"publisher","unstructured":"Saffari, A., Br\u00f6sse, I., Wiemer-Kruel, A., Wilken, B., Kreuzaler, P., Hahn, A., Bernhard,M. K., van Tilburg, C. M., Hoffmann, G. F., Gorenflo, M., Hethey, S., Kaiser, O.,K\u00f6lker, S., Wagner, R., Witt, O., Merkenschlager, A., M\u00f6ckel, A., Roser, T., Schlump,J. U., Serfling, A. Syrbe, S. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study. Orphanet journal of rare diseases. 2019;14(1):96. https:\/\/doi.org\/10.1186\/s13023-019-1077-6.","DOI":"10.1186\/s13023-019-1077-6"},{"key":"4921_CR7","doi-asserted-by":"publisher","unstructured":"Iris E, Overwater Andr\u00e9B, Rietman SE, van der Mous FE, Jansen Y, Elgersma HA, de Moll, Marie-Claire Y. Wit. A randomized controlled trial with everolimus for IQ and autism in tuberous sclerosis complex. Neurology. 2019;93(2):e200-e209; https:\/\/doi.org\/10.1212\/WNL.0000000000007749.","DOI":"10.1212\/WNL.0000000000007749"},{"issue":"12","key":"4921_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/acn3.494","volume":"4","author":"DA Krueger","year":"2017","unstructured":"Krueger DA, Sadhwani A, Byars AW, Vries PJ, Franz DN, Whittemore VH, Filip-Dhima R, Murray D, Kapur K, Sahin M. Everolimus for treatment of tuberous sclerosis complex\u2010associated neuropsychiatric disorders. Ann Clin Transl Neurol. 2017;4(12):877\u201387. https:\/\/doi.org\/10.1002\/acn3.494.","journal-title":"Ann Clin Transl Neurol"},{"key":"4921_CR9","doi-asserted-by":"publisher","unstructured":"Kadish NE, Riedel C, Stephani U, Wiegand G. Developmental outcomes in children\/adolescents and one adult with tuberous sclerosis complex (TSC) and refractory epilepsy treated with everolimus. Epilepsy & behavior: E&B. 2020;111:107182. https:\/\/doi.org\/10.1016\/j.yebeh.2020.107182.","DOI":"10.1016\/j.yebeh.2020.107182"},{"key":"4921_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2147\/NDT.S347327","volume":"19","author":"A Singh","year":"2023","unstructured":"Singh A, Hadjinicolaou A, Peters JM, Salussolia CL. Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions. Neuropsychiatr Dis Treat. 2023;19:733\u201348. https:\/\/doi.org\/10.2147\/NDT.S347327.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4921_CR11","doi-asserted-by":"publisher","unstructured":"Benedik, M. P., Carter, T., Dahlin, M., D\u00b4Amato, L., de Vries, P. J., Feucht, M.,Fladrowski, C., Macaya, A., O\u2019Callaghan, F., Sander, V., Shah, S., Youroukos, S.,Zonnenberg, B., Shinohara, N., Horie, S., Imai, K., Kaneda, M., Kaneko, H., Uchida,Y. Hartmann, H. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study. Epilepsia Open. 2019;4(1):73\u201384. https:\/\/doi.org\/10.1002\/epi4.12286.","DOI":"10.1002\/epi4.12286"},{"issue":"2","key":"4921_CR12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1528-1167.2008.01788.x","volume":"50","author":"DA Muzykewicz","year":"2009","unstructured":"Muzykewicz DA, Costello DJ, Halpern EF, Thiele EA. Infantile spasms in tuberous sclerosis complex: Prognostic utility of EEG. Epilepsia (Copenhagen). 2009;50(2):290\u20136. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01788.x.","journal-title":"Epilepsia (Copenhagen)"},{"issue":"2","key":"4921_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0920-1211(96)01006-6","volume":"26","author":"C Chiron","year":"1997","unstructured":"Chiron C, Dumas C, Jambaqu\u00e9 I, Mumford J, Dulac O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 1997;26(2):389\u201395. https:\/\/doi.org\/10.1016\/S0920-1211(96)01006-6.","journal-title":"Epilepsy Res"},{"issue":"8","key":"4921_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/0883073818768309","volume":"33","author":"EA Van der Poest Clement","year":"2018","unstructured":"Van der Poest Clement EA, Sahin M, Peters JM. Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex. J Child Neurol. 2018;33(8):519\u201324. https:\/\/doi.org\/10.1177\/0883073818768309.","journal-title":"J Child Neurol"},{"key":"4921_CR15","doi-asserted-by":"publisher","unstructured":"Bebin, E. M., Peters, J. M., Porter, B. E., McPherson, T. O., O\u2019Kelley, S., Sahin,M., Taub, K. S., Rajaraman, R., Randle, S. C., McClintock, W. M., Koenig, M. K., Frost,M. D., Northrup, H., Werner, K., Nolan, D. A., Wong, M., Krefting, J. L., Biasini,F., Peri, K., \u2026 Krueger, D. A. Early Treatment with Vigabatrin Does Not Decrease Focal Seizures or Improve Cognition in Tuberous Sclerosis Complex: The PREVeNT Trial.Annals of Neurology. 2024;95(1):15\u201326. https:\/\/doi.org\/10.1002\/ana.26778.","DOI":"10.1002\/ana.26778"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04921-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04921-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:03:29Z","timestamp":1783605809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04921-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4921"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04921-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local institutional IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the clinical details from this patient\u2019s guardian were obtained. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}